GlassScriptPhysician profile
Mildred Woodruff
NPI 1629362199
$1,134.08
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,081 · 2023: $53.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $53.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $53.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $158.47 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $132.61 | 2021 | |
| Lilly USA, LLC | $129.23 | 2021 | |
| Abbvie INC. | $126.02 | 2021-2023 | |
| Radius Health, INC. | $95.87 | 2021 | |
| Esperion Therapeutics, INC. | $80.43 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $76.17 | 2021 | |
| Amgen INC. | $70.60 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $58.69 | 2021 | |
| Pfizer INC. | $58.25 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $56.53 | 2021 | |
| Clarus Therapeutics INC. | $21.18 | 2021 | |
| Hologic Sales and Service, LLC | $20.86 | 2023 | Aptima |
| Amarin Pharma, INC. | $19.83 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.70 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $11.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mildred Woodruff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.